This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01310946
First received: March 6, 2011
Last updated: December 11, 2011
Last verified: December 2011
  Purpose
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Condition Intervention
Acute Lymphocytic Leukemia Other: Database

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Resource links provided by NLM:


Further study details as provided by King Faisal Specialist Hospital & Research Center:

Estimated Enrollment: 203
Study Start Date: June 2003
Intervention Details:
    Other: Database
    Database
Detailed Description:
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology
  Eligibility

Ages Eligible for Study:   14 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Acute Lymphocytic Leukemia Database
Criteria

Inclusion Criteria:

  • Patients with diagnosed Acute Lymphocytic Leukemia

Exclusion Criteria:

  • Patients with diagnosis other than Acute Lymphocytic Leukemia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01310946

Contacts
Contact: N Chaudhri, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: N Chaudhri, M.D. KFSH & RC
  More Information

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01310946     History of Changes
Other Study ID Numbers: RAC# 2021-051
RAC# 2021-051 ( Other Identifier: KFSH&RC )
Study First Received: March 6, 2011
Last Updated: December 11, 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
Acute Lymphocytic Leukemia

Additional relevant MeSH terms:
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on August 18, 2017